vs

Side-by-side financial comparison of Invesco (IVZ) and Ralph Lauren Corporation (RL). Click either name above to swap in a different company.

Ralph Lauren Corporation is the larger business by last-quarter revenue ($2.4B vs $1.7B, roughly 1.4× Invesco). Ralph Lauren Corporation runs the higher net margin — 15.0% vs -58.9%, a 73.9% gap on every dollar of revenue. On growth, Ralph Lauren Corporation posted the faster year-over-year revenue change (12.2% vs 6.2%). Ralph Lauren Corporation produced more free cash flow last quarter ($704.0M vs $432.2M). Over the past eight quarters, Ralph Lauren Corporation's revenue compounded faster (23.9% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Ralph Lauren is an American fashion designer, philanthropist, and billionaire businessman, best known for founding the brand Ralph Lauren, a global multibillion-dollar enterprise. He stepped down as CEO of the company in September 2015 but remains executive chairman and chief creative officer. As of May 2025, his net worth is estimated at US$11.9 billion.

IVZ vs RL — Head-to-Head

Bigger by revenue
RL
RL
1.4× larger
RL
$2.4B
$1.7B
IVZ
Growing faster (revenue YoY)
RL
RL
+6.0% gap
RL
12.2%
6.2%
IVZ
Higher net margin
RL
RL
73.9% more per $
RL
15.0%
-58.9%
IVZ
More free cash flow
RL
RL
$271.8M more FCF
RL
$704.0M
$432.2M
IVZ
Faster 2-yr revenue CAGR
RL
RL
Annualised
RL
23.9%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IVZ
IVZ
RL
RL
Revenue
$1.7B
$2.4B
Net Profit
$-995.9M
$361.6M
Gross Margin
69.9%
Operating Margin
-86.2%
19.6%
Net Margin
-58.9%
15.0%
Revenue YoY
6.2%
12.2%
Net Profit YoY
-575.8%
21.6%
EPS (diluted)
$-2.61
$5.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
RL
RL
Q4 25
$1.7B
$2.4B
Q3 25
$1.6B
$2.0B
Q2 25
$1.5B
$1.7B
Q1 25
$1.5B
$1.7B
Q4 24
$1.6B
$2.1B
Q3 24
$1.5B
$1.7B
Q2 24
$1.5B
$1.5B
Q1 24
$1.5B
$1.6B
Net Profit
IVZ
IVZ
RL
RL
Q4 25
$-995.9M
$361.6M
Q3 25
$356.4M
$207.5M
Q2 25
$197.4M
$220.4M
Q1 25
$171.1M
$129.0M
Q4 24
$209.3M
$297.4M
Q3 24
$55.0M
$147.9M
Q2 24
$132.2M
$168.6M
Q1 24
$141.5M
$90.7M
Gross Margin
IVZ
IVZ
RL
RL
Q4 25
69.9%
Q3 25
68.0%
Q2 25
72.3%
Q1 25
68.7%
Q4 24
68.4%
Q3 24
67.0%
Q2 24
70.5%
Q1 24
66.6%
Operating Margin
IVZ
IVZ
RL
RL
Q4 25
-86.2%
19.6%
Q3 25
16.5%
12.2%
Q2 25
14.1%
15.9%
Q1 25
18.1%
9.1%
Q4 24
19.6%
18.2%
Q3 24
6.6%
10.4%
Q2 24
13.9%
13.8%
Q1 24
14.4%
6.9%
Net Margin
IVZ
IVZ
RL
RL
Q4 25
-58.9%
15.0%
Q3 25
21.7%
10.3%
Q2 25
13.0%
12.8%
Q1 25
11.2%
7.6%
Q4 24
13.1%
13.9%
Q3 24
3.6%
8.6%
Q2 24
8.9%
11.1%
Q1 24
9.6%
5.8%
EPS (diluted)
IVZ
IVZ
RL
RL
Q4 25
$-2.61
$5.82
Q3 25
$0.66
$3.32
Q2 25
$-0.03
$3.52
Q1 25
$0.38
$2.03
Q4 24
$0.46
$4.66
Q3 24
$0.12
$2.31
Q2 24
$0.29
$2.61
Q1 24
$0.31
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
RL
RL
Cash + ST InvestmentsLiquidity on hand
$1.0B
$2.3B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$12.2B
$2.9B
Total Assets
$27.1B
$7.8B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
RL
RL
Q4 25
$1.0B
$2.3B
Q3 25
$973.1M
$1.6B
Q2 25
$922.7M
$2.3B
Q1 25
$821.7M
$2.1B
Q4 24
$986.5M
$2.1B
Q3 24
$1.0B
$1.7B
Q2 24
$878.5M
$1.8B
Q1 24
$895.7M
$1.8B
Total Debt
IVZ
IVZ
RL
RL
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
IVZ
IVZ
RL
RL
Q4 25
$12.2B
$2.9B
Q3 25
$14.0B
$2.6B
Q2 25
$13.9B
$2.5B
Q1 25
$14.7B
$2.6B
Q4 24
$14.6B
$2.5B
Q3 24
$14.8B
$2.4B
Q2 24
$14.6B
$2.4B
Q1 24
$14.6B
$2.5B
Total Assets
IVZ
IVZ
RL
RL
Q4 25
$27.1B
$7.8B
Q3 25
$28.4B
$7.3B
Q2 25
$28.5B
$7.8B
Q1 25
$28.1B
$7.0B
Q4 24
$27.0B
$7.1B
Q3 24
$27.5B
$6.8B
Q2 24
$27.2B
$6.6B
Q1 24
$28.1B
$6.6B
Debt / Equity
IVZ
IVZ
RL
RL
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
RL
RL
Operating Cash FlowLast quarter
$455.8M
$779.6M
Free Cash FlowOCF − Capex
$432.2M
$704.0M
FCF MarginFCF / Revenue
25.5%
29.3%
Capex IntensityCapex / Revenue
1.4%
3.1%
Cash ConversionOCF / Net Profit
2.16×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$694.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
RL
RL
Q4 25
$455.8M
$779.6M
Q3 25
$606.2M
$53.2M
Q2 25
$547.9M
$176.1M
Q1 25
$-84.6M
$122.2M
Q4 24
$316.9M
$738.4M
Q3 24
$438.4M
$97.2M
Q2 24
$489.1M
$277.3M
Q1 24
$-54.4M
Free Cash Flow
IVZ
IVZ
RL
RL
Q4 25
$432.2M
$704.0M
Q3 25
$586.4M
$-40.6M
Q2 25
$530.4M
$-11.2M
Q1 25
$-108.0M
$42.3M
Q4 24
$309.9M
$677.2M
Q3 24
$410.0M
$55.5M
Q2 24
$462.4M
$243.9M
Q1 24
$-75.4M
FCF Margin
IVZ
IVZ
RL
RL
Q4 25
25.5%
29.3%
Q3 25
35.7%
-2.0%
Q2 25
35.0%
-0.7%
Q1 25
-7.1%
2.5%
Q4 24
19.5%
31.6%
Q3 24
27.1%
3.2%
Q2 24
31.2%
16.1%
Q1 24
-5.1%
Capex Intensity
IVZ
IVZ
RL
RL
Q4 25
1.4%
3.1%
Q3 25
1.2%
4.7%
Q2 25
1.2%
10.9%
Q1 25
1.5%
4.7%
Q4 24
0.4%
2.9%
Q3 24
1.9%
2.4%
Q2 24
1.8%
2.2%
Q1 24
1.4%
Cash Conversion
IVZ
IVZ
RL
RL
Q4 25
2.16×
Q3 25
1.70×
0.26×
Q2 25
2.78×
0.80×
Q1 25
-0.49×
0.95×
Q4 24
1.51×
2.48×
Q3 24
7.97×
0.66×
Q2 24
3.70×
1.64×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

RL
RL

Segment breakdown not available.

Related Comparisons